Expert Opinion on Drug Safety, Volume 16, Issue 3 (2017)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 16, Issue 3 (2017)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Volume 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Original Research

Article
Signal detection activity on EudraVigilance data: analysis of the procedure and findings from an Italian Regional Centre for Pharmacovigilance
Luca Monaco, Mauro Melis, Chiara Biagi, Monia Donati, Ester Sapigni, Alberto Vaccheri & Domenico Motola
Pages: 271-275
Published online: 30 Jan 2017
AbstractforSignal detection activity on EudraVigilance data: analysis of the procedure and findings from an Italian Regional Centre for Pharmacovigilance | Full Text | References | PDF (533.4 KB)
  • 360 Views
  • 3 CrossRef citations
  • 0Altmetric

Review

Review
The Safety of available immunotherapy for the treatment of glioblastoma
S. Harrison Farber, Aladine A. Elsamadicy, Ahmet Fatih Atik, Carter M. Suryadevara, Pakawat Chongsathidkiet, Peter E. Fecci & John H. Sampson
Pages: 277-287
Published online: 03 Jan 2017
AbstractforThe Safety of available immunotherapy for the treatment of glioblastoma | Full Text | References | PDF (1.1 MB)
  • 502 Views
  • 18 CrossRef citations
  • 0Altmetric
Review
The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis
J. Braun & J. Kay
Pages: 289-302
Published online: 10 Jan 2017
AbstractforThe safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis | Full Text | References | PDF (1 MB)
  • 740 Views
  • 13 CrossRef citations
  • 0Altmetric
Review
Therapeutic drug monitoring of anti-tumour necrosis factor-α agents in inflammatory bowel disease
Nikola Mitrev & Rupert W. Leong
Pages: 303-317
Published online: 22 Dec 2016
AbstractforTherapeutic drug monitoring of anti-tumour necrosis factor-α agents in inflammatory bowel disease | Full Text | References | PDF (1.6 MB)
  • 979 Views
  • 20 CrossRef citations
  • 0Altmetric
Review
Challenges in molecular targeted therapy for gastric cancer: considerations for efficacy and safety
Yukiya Narita & Kei Muro
Pages: 319-327
Published online: 25 Dec 2016
AbstractforChallenges in molecular targeted therapy for gastric cancer: considerations for efficacy and safety | Full Text | References | PDF (859.2 KB)
  • 477 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
An update on the safety and interactions of antifungal drugs in stem cell transplant recipients
Corrado Girmenia & Anna Paola Iori
Pages: 329-339
Published online: 26 Dec 2016
AbstractforAn update on the safety and interactions of antifungal drugs in stem cell transplant recipients | Full Text | References | PDF (814.8 KB)
  • 1038 Views
  • 17 CrossRef citations
  • 0Altmetric
Review
Clinical benefits and drawbacks of local corticosteroids injections in tendinopathies
Michele Abate, Vincenzo Salini, Cosima Schiavone & Isabel Andia
Pages: 341-349
Published online: 28 Dec 2016
AbstractforClinical benefits and drawbacks of local corticosteroids injections in tendinopathies | Full Text | References | PDF (812.3 KB)
  • 588 Views
  • 17 CrossRef citations
  • 0Altmetric
Review
Cardiovascular safety and benefits of GLP-1 receptor agonists
Niels B. Dalsgaard, Andreas Brønden, Tina Vilsbøll & Filip K. Knop
Pages: 351-363
Published online: 19 Jan 2017
AbstractforCardiovascular safety and benefits of GLP-1 receptor agonists | Full Text | References | PDF (1.2 MB)
  • 1294 Views
  • 28 CrossRef citations
  • 0Altmetric

Drug Safety Evaluation

Article
Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation
M. C. Mauri, A. Reggiori, S. Paletta, C. Di Pace & A. C. Altamura
Pages: 365-379
Published online: 09 Feb 2017
AbstractforPaliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation | Full Text | References | PDF (1.1 MB)
  • 773 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
Safety evaluation of apremilast for the treatment of psoriasis
A. Dattola, E. Del Duca, R. Saraceno, T. Gramiccia & L. Bianchi
Pages: 381-385
Published online: 07 Feb 2017
AbstractforSafety evaluation of apremilast for the treatment of psoriasis | Full Text | References | PDF (446.4 KB)
  • 722 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Efficacy and safety of fixed-ratio combination of insulin degludec and liraglutide (IDegLira) for the treatment of type 2 diabetes
Louise Vedtofte, Filip K. Knop & Tina Vilsbøll
Pages: 387-396
Published online: 15 Feb 2017
AbstractforEfficacy and safety of fixed-ratio combination of insulin degludec and liraglutide (IDegLira) for the treatment of type 2 diabetes | Full Text | References | PDF (877.9 KB)
  • 1253 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
The safety of mepolizumab for the treatment of asthma
E Leung, K Al Efraij & JM FitzGerald
Pages: 397-404
Published online: 01 Feb 2017
AbstractforThe safety of mepolizumab for the treatment of asthma | Full Text | References | PDF (561.9 KB)
  • 896 Views
  • 19 CrossRef citations
  • 0Altmetric
Article
Efficacy and safety of a recombinant factor VIII produced from a human cell line (simoctocog alfa)
Massimo Franchini & Pier Mannuccio Mannucci
Pages: 405-410
Published online: 01 Feb 2017
AbstractforEfficacy and safety of a recombinant factor VIII produced from a human cell line (simoctocog alfa) | Full Text | References | PDF (499.8 KB)
  • 511 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Hydroxychloroquine in systemic lupus erythematosus (SLE)
C. Ponticelli & G. Moroni
Pages: 411-419
Published online: 14 Dec 2016
AbstractforHydroxychloroquine in systemic lupus erythematosus (SLE) | Full Text | References | PDF (760 KB)
  • 6891 Views
  • 194 CrossRef citations
  • 0Altmetric

Corrigendum

Correction
Corrigendum
Page: 421
Published online: 15 Feb 2017
CitationforCorrigendum | Full Text | PDF (85.4 KB)
  • 446 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles